A lung cancer trial bolsters a long-held idea that treatment timing matters, showing a simple shift could help immunotherapy ...

A gene therapy that patients breathe in has been found to shrink lung tumours by inserting immune-boosting genes into ...

FDA RMAT boosts inhaled gene therapy KB707, delivering IL‑2/IL‑12 to lung tumors; early trial shows responses with manageable ...

The FDA has approved Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as the first and only subcutaneous, chemo-free ...

A new study published by Mayo Clinic researchers suggests that ovarian cancer cells quickly activate a survival response ...

New targeted drugs transform HER2, ROS1 and ALK lung cancer care, boosting brain response and survival—while precision choices still matter.

A new randomized clinical trial showed that receiving immunochemotherapy infusions earlier in the day may help patients with ...

Heather Quintana Suchan, a mother and music industry professional living with stage 4 lung cancer, shared how her diagnosis ...

Researchers recently tried an experiment: Gather people who had the same kind of lung cancer and put them on the same type of treatments to fire up their immune systems. The only difference was that ...

Targeted therapies are cancer medications that work more selectively than standard chemotherapy medications. They do this by targeting specific molecules or genetic changes in cancer cells in order to ...

Survivors of non-small cell lung cancer are at risk for both second primary lung cancers as well as non-lung secondary ...